GASCOGNE (ALBI.PA) Fundamental Analysis & Valuation

EPA:ALBI • FR0000124414

Current stock price

2.16 EUR
-0.02 (-0.92%)
Last:

This ALBI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ALBI.PA Profitability Analysis

1.1 Basic Checks

  • ALBI had negative earnings in the past year.
  • In the past year ALBI had a positive cash flow from operations.
  • ALBI had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years ALBI had a positive operating cash flow.
ALBI.PA Yearly Net Income VS EBIT VS OCF VS FCFALBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

  • With a Return On Assets value of 0.15%, ALBI is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
  • ALBI has a Return On Equity of 0.44%. This is in the lower half of the industry: ALBI underperforms 63.64% of its industry peers.
  • ALBI has a Return On Invested Capital of 1.31%. This is in the lower half of the industry: ALBI underperforms 63.64% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ALBI is below the industry average of 7.07%.
Industry RankSector Rank
ROA 0.15%
ROE 0.44%
ROIC 1.31%
ROA(3y)2.18%
ROA(5y)2.37%
ROE(3y)5.63%
ROE(5y)6.16%
ROIC(3y)4.1%
ROIC(5y)4.24%
ALBI.PA Yearly ROA, ROE, ROICALBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

  • ALBI has a Profit Margin of 0.23%. This is in the lower half of the industry: ALBI underperforms 63.64% of its industry peers.
  • Looking at the Operating Margin, with a value of 2.17%, ALBI is doing worse than 63.64% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ALBI has declined.
  • The Gross Margin of ALBI (26.06%) is worse than 72.73% of its industry peers.
  • ALBI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.17%
PM (TTM) 0.23%
GM 26.06%
OM growth 3Y-27.15%
OM growth 5Y-15.85%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y-1.26%
ALBI.PA Yearly Profit, Operating, Gross MarginsALBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ALBI.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALBI is creating some value.
  • The number of shares outstanding for ALBI has been increased compared to 1 year ago.
  • Compared to 5 years ago, ALBI has more shares outstanding
  • The debt/assets ratio for ALBI is higher compared to a year ago.
ALBI.PA Yearly Shares OutstandingALBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ALBI.PA Yearly Total Debt VS Total AssetsALBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • ALBI has an Altman-Z score of 1.28. This is a bad value and indicates that ALBI is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.28, ALBI is in line with its industry, outperforming 45.45% of the companies in the same industry.
  • ALBI has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
  • ALBI has a Debt to Equity ratio (1.16) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Altman-Z 1.28
ROIC/WACC0.41
WACC3.21%
ALBI.PA Yearly LT Debt VS Equity VS FCFALBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.60 indicates that ALBI should not have too much problems paying its short term obligations.
  • ALBI's Current ratio of 1.60 is in line compared to the rest of the industry. ALBI outperforms 45.45% of its industry peers.
  • ALBI has a Quick Ratio of 1.60. This is a bad value and indicates that ALBI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.86, ALBI is in line with its industry, outperforming 54.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 0.86
ALBI.PA Yearly Current Assets VS Current LiabilitesALBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. ALBI.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 102.10% over the past year.
  • The Revenue has been growing slightly by 7.25% in the past year.
  • The Revenue has been growing slightly by 0.07% on average over the past years.
EPS 1Y (TTM)102.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.36%
Revenue 1Y (TTM)7.25%
Revenue growth 3Y-0.64%
Revenue growth 5Y0.07%
Sales Q2Q%6.98%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBI.PA Yearly Revenue VS EstimatesALBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALBI.PA Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBI.PA Price Earnings VS Forward Price EarningsALBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • ALBI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ALBI is cheaper than 63.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.48
ALBI.PA Per share dataALBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALBI.PA Dividend Analysis

5.1 Amount

  • ALBI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALBI.PA Fundamentals: All Metrics, Ratios and Statistics

GASCOGNE

EPA:ALBI (4/7/2026, 7:00:00 PM)

2.16

-0.02 (-0.92%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.62%
Ins Owner ChangeN/A
Market Cap81.39M
Revenue(TTM)404.78M
Net Income(TTM)927.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF 20.75
P/B 0.39
P/tB 0.41
EV/EBITDA 8.48
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.41
FCFYN/A
OCF(TTM)0.1
OCFY4.82%
SpS10.74
BVpS5.6
TBVpS5.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.15%
ROE 0.44%
ROCE 1.94%
ROIC 1.31%
ROICexc 1.32%
ROICexgc 1.36%
OM 2.17%
PM (TTM) 0.23%
GM 26.06%
FCFM N/A
ROA(3y)2.18%
ROA(5y)2.37%
ROE(3y)5.63%
ROE(5y)6.16%
ROIC(3y)4.1%
ROIC(5y)4.24%
ROICexc(3y)4.63%
ROICexc(5y)4.82%
ROICexgc(3y)4.81%
ROICexgc(5y)5.01%
ROCE(3y)6.32%
ROCE(5y)6.56%
ROICexgc growth 3Y-40.81%
ROICexgc growth 5Y-24.33%
ROICexc growth 3Y-40.44%
ROICexc growth 5Y-24.35%
OM growth 3Y-27.15%
OM growth 5Y-15.85%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y-1.26%
F-Score6
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Debt/EBITDA 6.86
Cap/Depr 211.44%
Cap/Sales 14.1%
Interest Coverage 2.15
Cash Conversion 10.96%
Profit Quality N/A
Current Ratio 1.6
Quick Ratio 0.86
Altman-Z 1.28
F-Score6
WACC3.21%
ROIC/WACC0.41
Cap/Depr(3y)285.57%
Cap/Depr(5y)222.94%
Cap/Sales(3y)15.49%
Cap/Sales(5y)11.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.25%
Revenue growth 3Y-0.64%
Revenue growth 5Y0.07%
Sales Q2Q%6.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y242.27%
EBIT growth 3Y-27.62%
EBIT growth 5Y-15.79%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.89%
OCF growth 3Y-14.16%
OCF growth 5Y0.18%

GASCOGNE / ALBI.PA Fundamental Analysis FAQ

What is the fundamental rating for ALBI stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALBI.PA.


What is the valuation status of GASCOGNE (ALBI.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to GASCOGNE (ALBI.PA). This can be considered as Overvalued.


What is the profitability of ALBI stock?

GASCOGNE (ALBI.PA) has a profitability rating of 2 / 10.